Alkem Laboratories Ltd (ALKE)

Currency in INR
5,018.45
+20.65(+0.41%)
Closed·
ALKE Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Earnings results expected in 12 days
Fair Value
Day's Range
4,992.555,042.75
52 wk Range
4,498.906,440.00
Key Statistics
Bid/Ask
4,920.00 / 5,018.45
Prev. Close
4,997.8
Open
4,993.45
Day's Range
4,992.55-5,042.75
52 wk Range
4,498.9-6,440
Volume
1.25K
Average Volume (3m)
44.21K
1-Year Change
-5.24%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALKE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Alkem Laboratories Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Alkem Laboratories Ltd Company Profile

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.

Employees
18785
Market
India

Compare ALKE to Peers and Sector

Metrics to compare
ALKE
Peers
Sector
Relationship
P/E Ratio
27.7x33.6x−0.5x
PEG Ratio
1.341.010.00
Price/Book
5.0x5.5x2.6x
Price / LTM Sales
4.6x4.5x3.2x
Upside (Analyst Target)
1.9%5.4%41.4%
Fair Value Upside
Unlock−1.8%6.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 181.11%
Dividend Yield
0.90%
Industry Median 0.74%
Annualised payout
45.00
Paid unevenly
5-Years Growth
+12.47%
Growth Streak

Earnings

Latest Release
May 28, 2025
EPS / Forecast
25.60 / 34.00
Revenue / Forecast
31.44B / 31.18B
EPS Revisions
Last 90 days

ALKE Income Statement

People Also Watch

394.15
BION
-0.87%
243.45
BOB
-1.38%
136.22
UNBK
-6.04%
421.80
HPCL
-3.01%
2,145.30
GLEN
+0.05%

FAQ

What Stock Exchange Does Alkem Laboratories Ltd Trade On?

Alkem Laboratories Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Alkem Laboratories Ltd?

The stock symbol for Alkem Laboratories Ltd is "ALKE."

What Is the Alkem Laboratories Ltd Market Cap?

As of today, Alkem Laboratories Ltd market cap is 599.25B.

What Is Alkem Laboratories Ltd's Earnings Per Share (TTM)?

The Alkem Laboratories Ltd EPS (TTM) is 181.11.

When Is the Next Alkem Laboratories Ltd Earnings Date?

Alkem Laboratories Ltd will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is ALKE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Alkem Laboratories Ltd Stock Split?

Alkem Laboratories Ltd has split 0 times.

How Many Employees Does Alkem Laboratories Ltd Have?

Alkem Laboratories Ltd has 18785 employees.

What is the current trading status of Alkem Laboratories Ltd (ALKE)?

As of 27 Jul 2025, Alkem Laboratories Ltd (ALKE) is trading at a price of 5,018.45, with a previous close of 4,997.80. The stock has fluctuated within a day range of 4,992.55 to 5,042.75, while its 52-week range spans from 4,498.90 to 6,440.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.